THE ANTI-PLATELET EFFECT OF DIFFERENT LOADING DOSE OF TICAGRELOR IN PATIENTS WITH NON-ST ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY

Background Early and effective platelet inhibition is necessary in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing percutaneous coronary intervention (PCI).

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.1497-1497
Main Authors: Huiliang, Liu, Wei, Yu-Jie, Jin, Zhi-Geng, Ding, Peng, Yang, Sheng-Li, Luo, Jian-Ping, Ma, Dong-Xing, Liu, Ying, Han, Wei, Zhang, Jiao, Li, Tianchang, Wang, Bing, Wang, Ming-Sheng, Li, Yun-Tian, Zhang, Jian-Jun, Ren, Yi-Hong, Tang, Qiang
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Angina pectoris
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Early and effective platelet inhibition is necessary in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing percutaneous coronary intervention (PCI).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)31498-X